Isolated hemopericardium after initiation of rivaroxaban: Implications and potential mechanisms

Adwait Mehta, David Burkland, Nilesh Mathuria

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Direct oral anticoagulants have become increasingly used for atrial fibrillation and venothromboembolic disease. Thus far, there have been a few published cases of pericardial effusion associated with rivaroxban. However, there has been little published regarding the effects of concurrent medications and their effect on the cytochrome enzyme systems involved in rivaroxaban metabolism. We present a case of a 76-year-old female who develops a spontaneous haemopericardium after initiating rivaroxaban. After thorough medical reconciliation, we offer pharmacokinetic mechanisms that may have contributed to the haemopericardium. This case demonstrates the importance of reviewing patients medication lists and utilizing basic pharmacokinetics to prevent adverse events.

Original languageEnglish (US)
Article number1096
Pages (from-to)4-5
Number of pages2
JournalClinics and Practice
Issue number1
StatePublished - 2019


  • Direct oral anticoagulant
  • Peericardial effusion
  • Rivaroxaban

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Isolated hemopericardium after initiation of rivaroxaban: Implications and potential mechanisms'. Together they form a unique fingerprint.

Cite this